| Views | |
|---|---|
| Iron(III)‐tCDTA derivatives as MRI contrast agents: Increased T 1 relaxivities at higher magnetic field strength and pH sensing | 189 |
| July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | January 2026 | |
|---|---|---|---|---|---|---|---|
| Iron(III)‐tCDTA derivatives as MRI contrast agents: Increased T 1 relaxivities at higher magnetic field strength and pH sensing | 11 | 0 | 12 | 22 | 9 | 4 | 5 |
| Views | |
|---|---|
| 2020_Xie_etal.pdf | 93 |
